Nano-X Imaging Reports Q2 Earnings with Revenue Growth, Impairment Charge, and Restructuring Plan
Nano-X Imaging (NASDAQ:NNOX) reported a 37% year-over-year revenue increase to $4.2 million in the second quarter of 2026, driven by growth in teleradiology services, health IT consolidation, and AI/software sales. Teleradiology contributed $3 million while AI and software generated $1 million. Despite this positive trend, the company recorded a GAAP net loss of $55.5 million due to a non-cash impairment charge of $40.7 million related to its AI-related intangible assets. The firm is implementing cost-cutting measures including idling its South Korean chip line and reducing headcount in both Korea and Israel, aiming for annualized savings of about $2 million starting in 2027. Nano-X also raised an additional $8.5 million post-quarter-end through capital-raising activities to bolster cash reserves, which stood at $31.4 million as of June 30.
Tickers: $NNOX
Topics: ai_development cost_reduction net_loss revenue_growth